GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human pd-L1 with monoclonal antibody avelumab

Analyse Crystal structure of human pd-L1 with monoclonal antibody avelumab in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5GRJ
Type
protein
Length
439 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Avelumab H chain; Avelumab L chain; Programmed cell death 1 ligand 1
UniProt
Q9NZQ7
Pockets
3 · best druggability 0.37

Structure

x-ray diffraction · 3 distinct chains · 2% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HAvelumab H chainprotein1183% helix, 50% strand—
LAvelumab L chainprotein1080% helix, 46% strand—
AProgrammed cell death 1 ligand 1protein2133% helix, 55% strandQ9NZQ7

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1790.370.7719empty
2910.360.7521empty
3800.300.7315empty

Interfaces

3 interfaces between chains.

  • H–L · 729 Ų buried · 6 hydrogen bonds · protein-protein
  • H–A · 690 Ų buried · 13 hydrogen bonds · protein-protein
  • L–A · 306 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 5GRJ · Crystal structure of human PD-L1 with monoclonal antibody avelumab · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.